{"url_path":"/sec/kytx/8-k/2026-05-18/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1994702/0001193125-26-227920-index.html","accession_number":"0001193125-26-227920","cik":"0001994702","ticker":"KYTX","issuer_name":"Kyverna Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1994702/0001193125-26-227920-index.html","primary_entity_key":"0001994702","primary_entity_name":"Kyverna Therapeutics, Inc."},"word_count":38,"has_tables":true,"body_markdown":"Item 8.01 Other Events.\n\n \n\nOn May 18, 2026, the Company issued a press release announcing the appointment of Mr. Martini as the Company’s Chief Financial Officer. A copy of the press release is filed herewith as Exhibit 99.1."}